FR 901379 (>90%)

1-[(4R,5R)-4,5-Dihydroxy-N2-(1-oxohexadecyl)-L-ornithine]-4-[(4S)-4-hydroxy-4-[4-hydroxy-3-(sulfooxy)phenyl]-L-threonine]pneumocandin A0; (2α,3β,4β)-(4R,5R)-4,5-Dihydroxy-N2-(1-oxohexadecyl)-L-ornithyl-L-threonyl-trans-4-hydroxy-L-prolyl-(S)-4-hydroxy-4-[4-hydroxy-3-(sulfooxy)phenyl]-L-threonyl-3-hydroxy-L-glutaminyl-3-hydroxy-4-methyl-L-Proline Cyclic (6→1)-Peptide; 1H-Dipyrrolo[2,1-c:2',1'-l][1,4,7,10,13,16]hexaazacycloheneicosine Cyclic Peptide Deriv.

O[C@H]([C@H](C1=CC(OS(O)(=O)=O)=C(O)C=C1)O)[C@H](NC2=O)C(N[C@@H]([C@H](O)CC(N)=O)C(N3C[C@H](C)[C@H](O)C3C(N[C@H](O)[C@H](O)C[C@H](NC(CCCCCCCCCCCCCCC)=O)C(N[C@@H]([C@H](O)C)C(N4C2C[C@@H](O)C4)=O)=O)=O)=O)=O